Results 241 to 250 of about 5,857,342 (337)

Genetic control of wheat flour end‐use quality and rheology by genome‐wide association studies

open access: yesThe Plant Genome, Volume 19, Issue 2, June 2026.
Abstract Improving end‐use quality in bread wheat (Triticum aestivum) requires dissecting the genetic basis of complex processing traits and deploying robust prediction pipelines in breeding. We performed genome‐wide association studies (GWASs) using 1767 high‐quality single‐nucleotide polymorphisms generated by genotyping‐by‐sequencing in a diverse ...
Juan Menor de Gaspar   +10 more
wiley   +1 more source

A study of intracoronary thrombolytic agents in high thrombus burden lesions during primary PCI. [PDF]

open access: yesIndian Heart J
Subrahmanya Sarma VR   +11 more
europepmc   +1 more source

Cardiovascular Health in Women—Across the Lifespan

open access: yesClinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar   +5 more
wiley   +1 more source

Prognostic Significance of Time Between Balloon and Peak CK-MB in AMI Patients Undergoing Primary PCI. [PDF]

open access: yesJACC Asia
Shibahashi E   +19 more
europepmc   +1 more source

Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real‐World: Results From the SCORE—Clinical ASCVD Study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4975-4990, June 2026.
ABSTRACT Aims To evaluate the association between semaglutide 2.4 mg and major adverse cardiovascular events (MACE) among adults with clinical atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity without diabetes in real‐world clinical practice.
Michael G. Nanna   +10 more
wiley   +1 more source

Acalabrutinib in Chronic Lymphocytic Leukemia: Pharmacology and Emerging Clinical Perspectives

open access: yesEuropean Journal of Haematology, Volume 116, Issue 6, Page 759-770, June 2026.
ABSTRACT Acalabrutinib, a second‐generation Bruton's tyrosine kinase inhibitor (BTKi), is characterized by enhanced specificity and selectivity for BTK with minimal off‐target effects, offering a significant evolution in the treatment of chronic lymphocytic leukemia (CLL). Its mechanism of action, a covalent binding to Cys481 within the BTK active site,
Gianluca Gaidano, Romano Danesi
wiley   +1 more source

Reduced adenosine receptor expression in ACS patients with no-reflow phenomenon undergoing primary PCI. [PDF]

open access: yesFuture Cardiol
Bagheri A   +4 more
europepmc   +1 more source

Outcomes of root canal treatment performed by undergraduate students: A systematic review and meta‐analysis

open access: yesInternational Endodontic Journal, Volume 59, Issue 6, Page 929-942, June 2026.
Abstract Background The outcomes of root canal treatment performed by students has not been well researched. Treatment outcomes of student clinicians directly correspond to the education they receive and therefore paves the way for future directions in endodontic education.
Philip Y.‐H. Chien   +3 more
wiley   +1 more source

SCAI Expert Consensus Statement on the Management of Patients With STEMI Referred for Primary PCI. [PDF]

open access: yesJ Soc Cardiovasc Angiogr Interv
Tamis-Holland JE   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy